Narrative review / 2017
Gut microbiome dysbiosis and resulting uremic toxins are implicated in chronic kidney disease progression, inflammation, and increased cardiovascular risk.
This review discusses the gut microbiome in chronic kidney disease (CKD), where dysbiosis arises from qualitative and quantitative changes in microbial profiles and disruption of gut barrier function. These alterations and host responses are implicated in CKD progression, uremic toxicity, inflammation, and increased cardiovascular risk. It also addresses the gut microbiome in renal transplant patients and explores therapeutic interventions aimed at restoring intestinal dysbiosis.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Patients with chronic kidney disease and renal transplant recipients
- What was measured
- Gut dysbiosis, uremic toxins, CKD progression, cardiovascular risk, and inflammation
THE PAPER
Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D. Transl Res, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.